Lupin Ltd

  • BSE Code : 500257
  • NSE Symbol : LUPIN
  • ISIN : INE326A01037
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 2,083.00 -15.10(-0.72%)

Open Price ()

2,088.10

Prev. Close ()

2,098.10

Volume (No’s)

1,194,290

Market Cap ()

95,248.48

Low Price ()

2,075.00

High Price ()

2,114.70

 

Corporate Announcement

08-Sep-2026 Lupin Limited - Analysts/Institutional Investor Meet/Con. Call Updates
04-Sep-2026 Lupin Limited - Press Release
25-Aug-2026 Lupin Limited - ESOP/ESOS/ESPS
17-Aug-2026 Lupin Limited - Press Release
12-Aug-2026 Lupin Limited - Analysts/Institutional Investor Meet/Con. Call Updates

Stock Summary

Market Cap(₹Cr.)

98,069.81

P/E (TTM)

14.81

Book value ()

659.00

Div Yield (%)

0.84

EPS (TTM)

144.81

Face Value ()

2.00

Technical Analysis

Key Level

Resistance 1

2,115.37

Resistance 2

2,132.63

Support 1

2,063.57

Support 2

2,029.03

Moving Average

30 Days

2,173.88

50 Days

2,278.87

100 Days

2,301.57

200 Days

2,256.81

Peers Group

Company Market Cap (₹in Cr.) P/E (x) P/B(x) EV / EBITDA(x) Dividend Yield(%) EPS
Lupin Ltd 98,069.81 14.81 3.51 8522.9 0.84 144.81
Sun Pharmaceutical Indust.. 440,397.93 138.32 18.85 6053.68 0.87 13.27
Divis Laboratories Ltd 248,664.42 83 9.43 3921 0.32 112.85
Torrent Pharmaceuticals L.. 182,738.23 89.1 16.9 4001.11 0.7 53.92
Zydus Lifesciences Ltd 115,012.19 31.55 3.7 5426 0.09 36.54

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made investment of Returns(%)

in Months Ago

My investment would be worth with a Loss of

Share Holding

CATEGORY NO. OF SHARES PERCENTAGE (%)
Total Foreign 104035524 22.75
Total Institutions 112691957 24.65
Total Govt Holding 9811 0.00
Total Non Promoter Corporate Holding 1564153 0.34
Total Promoters 214212684 46.85
Total Public & others 24718407 5.41
Total 457232536 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

Corporate Actions

About Company

Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments.

Lupin Limited was incorporated in 1983 as 'Lupin Chemicals Limited'. In March 2001, Lupin Laboratories Limited was amalgamated with the company and the name was changed to 'Lupin Limited'. In 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar. In 1989, the company established a joint venture in Thailand, namely Lupin Chemicals (Thailand) Ltd. In the year 1991, they initiated production of Injectable cephalosporin (bulk and dosages) at Mandideep. In 1992, the company set up Fermentation Plant at Tarapur, Maharashtra. Also, Sterile Plant for injectable Cephalosporins (bulk) was commissioned at Mandideep.

They commenced supply of Cephalosporin bulk actives to their alliance partners in the US. Also, they commissioned a...

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew